Year-end Sale % OFF 
Abstract
International Journal of Pharmacology and Clinical Sciences,2021,10,1,13-19.DOI:10.5530/ijpcs.2021.10.3Published:March 2021Type:Research ArticleAuthors:Yousef Ahmed Alomi, Nouf Hassan Alamoudi, Sabah Alanazi, and Abeer Hussin Almasoudi Author(s) affiliations:Yousef Ahmed Alomi*, BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE Critical Care Clinical Pharmacists, TPN clinical pharmacist, Freelancer Business Planner, Content Editor and Data Analyst Riyadh, Riyadh, SAUDI ARABIA. Nouf Hassan Alamoudi, PharmD, Umm Al-Qura University, Makkah, SAUDI ARABIA. Sabah Alanazi, B.D.S. Prince Sultan Medical Military City, Riyadh, SAUDI ARABIA. Abeer Hussin Almasoudi, BSc.Pharm Director, Administration of research and studies, Ministry of Health, Tabuk, SAUDI ARABIA. Abstract:Objectives: To discover the healthcare providers (physicians and dentists) practice of the adverse drug reaction reporting system in Saudi Arabia. Methods: It was a crosssectional study with a self-administered electronic authenticated survey distributed to Saudi Arabia physicians and dentists. The survey contained of demographic data and rudiments of practicing the ADR reporting system, the number of ADR reported, the method of ADR reporting systems. Results: The total number of participants was 151. Of those, 111 (73.5%) were physicians, while dentists were 39 (26.5%). Of those 52 (35.68%), only those who reported the ADR despite most responders 138 (92.62%) thought the ADR reporting system was critical. The average scores of physicians practice ADR elements were 2.59. The physicians and dentists’ responders had a high score of the agreement; ADR’s essential tasks as a pharmacist. Conclusion: Over the past twenty years, more than theory studies and our study specified that ADR physicians’ reporting was terrible. The switching accountability of ADR reporting from healthcare providers to the pharmacist is highly suggested. Keywords:Adverse drug reaction, Physician, Practice, Reporting, Saudi ArabiaView:PDF (279.83 KB) PDFClick here to download the PDF file. Images Physician’s Practice of Adverse Drug Reaction in Saudi Arabia
Highlights
The clinical pharmacy activity was well recognized in the Kingdom of Saudi Arabia for more than forty years.[1,2] The drug information services included among clinical pharmacy services.2 The drug information activities are well established, and adverse drug reaction reporting system comprised among those activities.[1,3] The reporting of the Adverse drug reaction (ADR) reporting system recognized altogether with drug information services.[4]
The ADR was recognized by drug information pharmacists and reported to the medication’s registration department at the Ministry of Health and recently reported to the Saudi Food and Drug Authority (SFDA).[4]
The results presented that only one-third of responders reported ADR
Summary
The clinical pharmacy activity was well recognized in the Kingdom of Saudi Arabia for more than forty years.[1,2] The drug information services included among clinical pharmacy services. The drug information activities are well established, and adverse drug reaction reporting system comprised among those activities.[1,3] The reporting of the ADR reporting system recognized altogether with drug information services.[4]. Multiple inquiries found the insufficient practice of physician’s knowledge, perception and practice the ADR reporting system among Saudi Arabia and some Arabic countries world-wide. [9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32] The reporting of ADR by physicians was found 5-34% only from 15 studies world-wide. In Saudi Arabia, the number of studies showed to assess practice toward ADR reporting or pharmacovigilance between healthcare professionals, in Dammam city, 135 participants (17 physicians of participants) designated 88.22% of the participants did not report ADRs More than 80 % did not get a training program about ADR and reporting system.[9,12,13,15,19,2124,26,28-32] In Saudi Arabia, the number of studies showed to assess practice toward ADR reporting or pharmacovigilance between healthcare professionals, in Dammam city, 135 participants (17 physicians of participants) designated 88.22% of the participants did not report ADRs
Sign-in/Register to view highlights & summary 
Paper version not known (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmacology and Clinical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
